Table 2 Oncological status stratified by BMI status
Variables | Underweight N=23 | Normal weight N=96 | Overweight N=82 | p value |
|---|---|---|---|---|
Tumor size | 4.04±2.43 | 3.91±2.03 | 3.53±1.94 | 0.377 |
Tumor number | 1.43±1.04 | 1.23±0.59 | 1.21±0.60 | 0.330 |
Tumor | ||||
Cholangiocarcinoma | 0 (0) | 6 (6.3) | 3 (3.7) | 0.389 |
Hepatocellular carcinoma | 18 (78.3) | 77 (80.2) | 68 (83.0) | |
Adenocarcinoma | 3 (13.0) | 5 (5.2) | 2 (2.4) | |
Metastatic hepatic | 2 (8.7) | 8 (8.3) | 9 (11.0) | |
UICC | ||||
Stage I | 8 (34.8%) | 34 (35.4%) | 27 (32.9%) | 0.822 |
Stage II | 7 (30.4%) | 46 (47.9%) | 38 (46.3%) | |
Stage IIIA | 2 (8.7%) | 10 (10.4%) | 13 (15.9%) | |
Stage IIIB | 4 (17.4%) | 5 (5.2%) | 4 (4.9%) | |
Stage IIIC | 2 (8.7%) | 1 (1.0%) | 0 (0) | |
Extent of live resection | ||||
Wedge | 4 (17.4) | 17 (17.7) | 22 (26.8) | 0.555 |
Segmentectomy | 15 (65.2) | 59 (61.5) | 48 (58.5) | |
Hemihepatectomy | 4 (17.4) | 20 (20.8) | 12 (14.6) | |